ArticleBioMed research international2022
Prevalence and Correlation of Metabolic Syndrome in Patients with Bipolar Disorder in NGHA, Riyadh.
Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
- Retracted: Prevalence and Correlation of Metabolic Syndrome in Patients with Bipolar Disorder in NGHA, Riyadh.BioMed research international · 2023Article
Corrections and comments
- Retraction · 2023-07-19Concerns/Issues about Data · Concerns/Issues about Human Subject Welfare · Concerns/Issues about Referencing/Attributions · Concerns/Issues about Peer Review · Investigation by Journal/Publisher · Investigation by Third Party · Lack of IRB/IACUC Approval and/or Compliance · Unreliable Results and/or Conclusions ·
- Retracted
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Metabolic syndrome is considered dangerous, especially to patients that are diagnosed with a mental condition such as bipolar disorder, since these types of patients can be difficult to deal with. Metabolic syndrome can lead to multiple cardiovascular diseases, strokes, and diabetes. A careful approach is important when it comes to facing a complex condition such as this. This research will contribute to giving more information about the prevalence and statistics of metabolic syndrome in bipolar disorder patients at NGHA, Riyadh. No published study in literature has investigated the prevalence of metabolic syndrome in patients with bipolar disorder in NGHA, Riyadh. Methods: The study was conducted among 191 adult male (66) and female (125) patients at NGHA, Riyadh. The medical records were used for the assessment of metabolic syndrome and referrals by using a chart review for individuals. The main variables are metabolic syndrome and bipolar disorder. It was conducted on both males and females. Data was collected on data collection form and further analysis on relations was made by using SAS (Version 9.4). Chi-squared test and the Wilcoxon Two-sample test for two-level continuous variables. Results: Out of 191 patients, 130 were obese, 85 had diabetes, and 89 were hypertensive. Additionally, 50 (40%) females and 29 (43.9%) males had metabolic syndrome, a total of 79 (41.4%) out of 191. Conclusion: The findings of this study indicate that there is an elevated prevalence of metabolic syndrome in bipolar disorder patients in NGHA, Riyadh. Highlighting the potential danger that people may not be aware of.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.